RenovoRx, Inc.
RNXTNasdaqCIK 1574094HealthcareFiscal year ends Dec 31
Reports and events: 89 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-2020:05 ET | 8-K | 8.01 Other events | 0001493152-26-039472 |
| 2026-08-1320:11 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-349190 |
| 2026-08-1320:06 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349157 |
| 2026-08-1220:16 ET | 8-K | 9.01 Financial statements and exhibits | 0001193125-26-346894 |
| 2026-08-0420:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-035995 |
| 2026-07-0212:30 ET | 8-K | 3.01 Delisting notice | 0001493152-26-031662 |
| 2026-06-3020:55 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-031303 |
| 2026-05-1521:25 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001193125-26-227256 |
| 2026-05-1420:19 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-224100 |
| 2026-05-1420:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-224080 |
| 2026-04-3020:00 ET | DEF 14A | Proxy statementPeriod 2026-04-30 | 0001493152-26-020403 |
| 2026-03-3021:38 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-013653 |
| 2026-03-3021:34 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-131928 |
| 2026-03-2711:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-013080 |
| 2026-03-2311:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-012058 |
| 2026-02-0612:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-005437 |
| 2026-01-0221:10 ET | 8-K | 3.01 Delisting notice | 0001493152-26-000113 |
| 2025-11-1421:55 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-023604 |
| 2025-11-1321:21 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-022325 |
| 2025-11-1321:12 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-022304 |
| 2025-08-1421:00 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-024147 |
| 2025-08-1420:08 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-024020 |
| 2025-06-2521:17 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-016512 |
| 2025-05-1520:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-010935 |
| 2025-05-1520:07 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-010895 |
| 2025-04-3021:13 ET | DEF 14A | Proxy statementPeriod 2025-04-30 | 0001641172-25-007884 |
| 2025-04-0113:00 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-002009 |
| 2025-04-0100:39 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-001932 |
| 2025-02-1014:14 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-005559 |
| 2024-11-1413:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045373 |
| 2024-11-1321:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-045137 |
| 2024-09-2520:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-038108 |
| 2024-08-1620:05 ET | 8-K | 4.01 Change of auditor | 0001493152-24-032812 |
| 2024-08-1321:03 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-031675 |
| 2024-06-0720:41 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-023128 |
| 2024-05-1021:21 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-018704 |
| 2024-05-0321:00 ET | 8-K | 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-017745 |
| 2024-04-3020:30 ET | DEF 14A | Proxy statementPeriod 2024-04-30 | 0001493152-24-017244 |
| 2024-04-1820:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-015192 |
| 2024-04-1612:00 ET | 8-K | 8.01 Other events | 0001493152-24-014742 |
| 2024-04-1513:00 ET | 8-K | 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-014559 |
| 2024-04-0920:15 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-014069 |
| 2024-04-0120:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-012357 |
| 2024-03-1420:53 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-009978 |
| 2024-02-2322:00 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001493152-24-007693 |
| 2024-02-0921:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-005711 |
| 2024-01-2914:06 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-004083 |
| 2024-01-0213:30 ET | 8-K | 8.01 Other events | 0001493152-24-000024 |
| 2023-12-1821:15 ET | 8-K | 5.07 Shareholder vote results | 0001493152-23-045272 |
| 2023-11-2718:23 ET | DEF 14A | Proxy statementPeriod 2023-11-27 | 0001493152-23-042751 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.